The deposition of gadolinium through ultrasound-induced blood-brain barrier (BBB) openings in the murine hippocampus was investigated. First, wave propagation simulations through the intact mouse skull revealed minimal beam distortion while thermal deposition simulations, at the same sonication parameters used to induce BBB opening in vivo, revealed temperature increases lower than 0.5
Introduction
Current treatments of neurological and neurodegenerative diseases are limited due to the inexistence of a truly noninvasive, transient and regionally selective brain drug delivery method (Pardridge 2005) . The brain is particularly difficult to deliver drugs to because of the blood-brain barrier (BBB), which is a selective and specialized vasculature that acts as a permeability barrier between the blood and brain. The impermeability of the BBB is due to tight junctions connecting adjacent endothelial cells and highly regulated transport systems of the endothelial cell membranes (Abbott et al 2006) . The main function of the BBB is ion and volume regulation in order to ensure conditions necessary for proper synaptic and axonal signaling (Stewart and Tuor 1994) . However, the same permeability properties that keep the brain healthy are the reason for the difficulty in the pharmacological treatment of the brain. The BBB prevents most neurologically potent drugs from entering the brain, and, as a result, has been determined as the rate-limiting factor in brain drug delivery (Pardridge 2005) . Until a solution to the trans-BBB delivery problem is found, treatments of neurological diseases will remain impeded.
A successful brain drug delivery method requires noninvasive, transient and regionally selective properties (Pardridge 2005) . Current BBB opening methods, such as chemical modification of drugs to increase permeability and invasive neurosurgical-based transcranial drug delivery, do not satisfy these properties simultaneously (Pardridge 2005) . To our knowledge, the only technique that has been shown to accommodate the necessary characteristics of a successful brain drug delivery method is focused ultrasound (FUS) with injected microbubbles.
The BBB opening induced by ultrasound at or near ablation intensities has been observed while often accompanied by neuronal damage (Bakay et al 1956 , Ballantine et al 1960 , Patrick et al 1990 , Vykhodtseva et al 1995 . After reducing the acoustic intensity and duty cycle, the BBB opening was still observed, but without macroscopic damage, e.g., thermal lesions (Mesiwala et al 2002) . With the addition of intravenously injected microbubbles prior to sonication, the BBB opening was determined to be transient (Hynynen et al 2001) . The advantage of having microbubbles present in the circulation is that they allow for the reduction of the ultrasound intensity so that most of the disruption is contained within the vasculature with reduced likelihood of irreversible neuronal damage (Hynynen et al 2003 , 2005 , 2005 , Sheikov et al 2004 , Choi et al 2005 . Although there are many indications that damage can be contained to minimal hemorrhage , the complete safety profile of the procedure remains to be realized. In addition, indications to various mechanisms such as the dilation of vessels, temporary ischemia, mechanically induced opening of the tight junctions and the activation of various transport mechanisms have been reported (Mesiwala et al 2002 , Sheikov et al 2004 . However, the complexity of mechanical, thermal and physiological interactions amongst the ultrasound, microbubbles and BBB physiology make this a difficult mechanism to completely understand (Apfel 1997 , Neppiras 1980 . The exact mechanism of the ultrasound-induced BBB opening has not been determined yet. Fortunately, the efficacy of this method is promising with molecules up to 20 nm in diameter being successfully delivered through the BBB . The implications of successful regional and noninvasive opening of the BBB using this method cannot be overemphasized. The ultrasound-induced BBB opening may allow for the delivery of neurologically potent drugs that have been previously shelved due to low BBB permeability or lack of regional specificity.
The study reported in this paper investigates the spatial and temporal variations of ultrasound-induced trans-BBB molecular delivery. All sonications were applied through the intact mouse skull and skin in vivo. No craniotomy was performed. Our group and others have shown that FUS can be applied transcranially (Choi et al 2005 , Kinoshita et al 2006 , Treat et al 2007 and with some studies characterizing the beam shape through the skull (Choi et al 2005 (Choi et al , 2006 . However, the reason for the signal intensity loss has not been elucidated yet. In this paper, using wave propagation simulations through µCT-scanned mouse skulls, it is shown that the loss in intensity is not due to the absorption from propagation through the skull, but to the reflection and refraction phenomena at the skull's surface, i.e., the location of the highest impedance mismatch. Previous studies have shown that MRI can be used as a method to determine the BBB opening in vivo (Hynynen et al 2001) . However, the studies revealed little information about the spatial and temporal variations of the model drug delivery. In this study, the molecular rate and path of diffusion were investigated in vivo using sequential, slow-contrast diffusion, high field MRI. Using the high resolution and high signal-to-noise ratio (SNR) attainable with this system, the shape of the BBB opening cannot only be determined by the shape of the ultrasound beam but also by the underlying vasculature of the sonicated region. The deposition of the model drug begins at specific sites, such as the posterior cerebral artery, before spreading to the brain parenchyma (figure 10).
Materials and methods
In the in vivo study, the ultrasound-induced BBB opening was performed through the intact skin and skull in each mouse. However, in order to accurately characterize the transcranial ultrasonic beam, the beam distortion due to the skull was predicted using two-dimensional finite-difference model simulations. In addition, temperature rise during the BBB opening was modeled and measured in tissue specimens in vitro. Thermal deposition was computed using the bio-heat equation to determine the temperature rise using the same parameters as those used to induce the BBB opening in vivo. The microbubble effect was not incorporated in the simulations although it is known that they can enhance heat deposition (Razansky et al 2006) . The purpose was to determine whether the effect of ultrasound energy deposition alone was sufficient to induce a temperature elevation large enough to cause physiological changes or thermal damage.
Simulations
2.1.1. Acoustic properties of the skull deduced from µCT images. A mouse (mass: 25 g, strain: C57BL/6, sex: male) head was severed and stabilized in a polypropylene conical tube. The tube was then placed in a µCT scanner (VivaCT 40, ScancoMedical, Inc., SWI; resolution: 10 µm thick), where three-dimensional µCT data were obtained. A single 10 µm two-dimensional coronal slice of the parietal bone was extracted from the µCT data. Although ultrasound propagation is a three-dimensional problem, the targeted skull region was found to have similar acoustic properties throughout the rest of the parietal bone region. The ultrasound beam and the targeted skull region were assumed to be axisymmetric. A threshold was applied to the µCT data and adjusted until the skull was isolated from the surrounding brain and skin tissue ( figure 1(a) ). The parietal bone was chosen because it was the skull region sonicated through to target the hippocampus in the in vivo study. Acoustic properties of the skull, i.e., density and speed of sound, were deduced from the skull µCT data using methods similar to those described by Aubry et al (2003) and modified for this study. The bone porosity ( ) mapping of the skull was obtained using the linear relationship between the porosity and the Hounsfield map (Aubry et al 2003) . To simplify the procedure, the lowest µCT data value of the skull was assumed to have a porosity of 1 while the highest value was set to 0 ( figure 1(b) ). Assuming that the skull was composed of only bone and water, the mass density (ρ) was deduced from the porosity using the following linear relationship (figure 1(c)):
The mass density of water (ρ water ) and the maximum mass density in the cortical bone (ρ bone ) were set to 1000 kg m −3 and 3170 kg m −3 , respectively. The speed of sound map was extracted from the porosity using a similar linear relationship (figure 1(d)): c = c water + (c bone − c water ) × (1 − ). The speed of sound in water (c water ) and cortical bone (c bone ) was set to 1.50 and 4.18 mm µs −1 , respectively. Ultrasonic absorption has no linear relationship with porosity. However, given the minuteness of the mouse skull (∼200 µm in thickness), the details of this relationship were deemed negligible. No absorption was assumed in the wave propagation simulation.
Wave propagation numerical simulations.
Simulations were performed with a finite-difference, wave propagation software (ACEL) developed by the Laboratoire Ondes et Acoustique, ESPCI, Paris, France (Tanter et al 1998 , Aubry et al 2003 . The wave propagation simulation program was based on the discretization of the linear acoustic wave equation in heterogeneous absorbing media (Aubry et al 2003) :
where p is the acoustic pressure, τ 0 is the relaxation time, ρ 0 is the density and c 0 is the speed of sound of the medium. The source term and gradient operator are S 0 and ∇, respectively. The equation accurately models fluids with the speed of sound, density and absorption heterogeneities. Mode conversions and shear waves were not taken into account in the approximations, because the incidence angle of the wavefront on the skull's interface was assumed nearly perpendicular. The details of the implementation of this equation are described by Aubry et al (2003) . The acoustic mappings of the skull were loaded into ACEL and simulated ultrasound sources were placed above the mouse skull with its beam axis 2 mm away from the sagittal suture. The focal point was placed 3 mm below the top of the mouse skull so that the ultrasound beam targeted the region of the hippocampus. The ultrasound sources were placed and designed according to the characteristics of the FUS transducer used in the ex vivo and in vivo experiments, as described later in this paper. Simulated acoustic pressure data were captured in a single dimension perpendicular to the beam axis and at the focal point, with and then without taking into account the skull's acoustic mappings.
Thermal deposition simulations.
Pressure amplitude measurements were obtained on ex vivo skulls as described in section 2.2.2. Using these measurements, temperature changes induced by an ultrasound transducer with sonication parameters set according to the values used to induce the BBB opening in vivo (frequency: 1.525 MHz, pressure amplitude: 0.67-1.10 MPa, burst rate: 10 Hz, burst duration: 20 ms, duration: four shots of 30 s sonication with 30 s delay between shots) were simulated. The temperature was computed using a threedimensional, finite-difference method based on the bio-heat equation (Pennes 1948 , Pernot et al 2004 :
where ρ is the density, C t is the specific heat capacity, T is the temperature and k is the thermal conductivity of the medium (i.e., brain tissue and water). The values were set to 1300 kg m −3 , 3370 J kg where α is the ultrasound absorption coefficient, p is the acoustic pressure and c is the speed of sound of the medium (i.e., brain tissue and water). The ultrasound absorption coefficient was set to 7.423 Np m −1 and the speed of sound was set to 1600 m s −1 . The pressure was varied according to the pressure used in our in vivo BBB opening study.
Experimental validation of simulations
2.2.1. Ultrasound equipment. Ultrasound waves were generated by a single-element spherical segment FUS transducer (center frequency: 1.525 MHz, focal depth: 90 mm, radius: 30 mm; Riverside Research Institute, New York, USA) with a circular hole (radius: 11.2 mm) in its center that held a pulse-echo diagnostic transducer (center frequency: 7.5 MHz, focal length: 60 mm), which was positioned so that the foci of the two transducers overlapped (figure 2). A cone filled with degassed and distilled water was mounted on the transducer system. The water was contained in the cone with a polyurethane membrane cap (Trojan; Church & Dwight Co., Inc., Princeton, NJ, USA). The transducer system was attached to a computer-controlled, three-dimensional positioning system (Velmex Inc., Lachine, QC, Canada). The FUS transducer was driven by a function generator (Agilent, Palo Alto, CA, USA) through a 50 dB power amplifier (ENI Inc., Rochester, NY, USA) while the diagnostic transducer was driven by a pulser-receiver system (Panametrics, Waltham, MA, USA) connected to a digitizer (Gage Applied Technologies, Inc., Lachine, QC, Canada), embedded in and controlled by a personal computer (PC).
Ex vivo skull experiments.
Six mice (mass: 20-25 g, strain: C57BL/6, sex: male) were euthanized, and each skull was excised and degassed in saline. The bottom tip of the cone of the transducer system was partially submerged in a degassed water-filled tank. A needle hydrophone (Precision Acoustics Ltd., Dorchester, Dorset, UK; needle diameter: 0.2 mm) was placed at the FUS transducer focus using the three-dimensional positioning system. The dimensions of the beam were measured by performing a three-dimensional raster scan (lateral step size: 0.2 mm, axial step size: 1.0 mm) of the FUS transducer beam. The peak-to-peak pressure amplitude was measured by calculating the difference between the peak-negative and peak-positive pressure values. The lateral and axial full-width at half-maximum (FWHM) intensities of the beam were calculated to be approximately 1.32 and 13.0 mm, respectively. In a set of six measurements, each mouse skull was held stationary at 3 mm above the tip of the hydrophone. Depth calculations were performed using the pulse-echo transducer and the range equation. The skull was placed so that the FUS beam targeted through the parietal bone, approximately 2 mm away from, and perpendicular to, the sagittal and lambdoid sutures (figure 3). So, in this setup, the hydrophone was placed in the same location that the FUS transducer targeted in the in vivo study: the hippocampus. Two-dimensional pressure fields were then measured in the presence and then in the absence of each skull.
In vitro liver experiments.
A 4 × 4 × 4 cm 3 segment of fresh bovine liver was cut and degassed in saline. Liver was selected, because it has acoustic properties close to those of brain tissues (Duck 1990 ). The mouse brain was not used since it was smaller and less rigid, making it difficult to keep intact when handling. In addition, thermal lesions are more easily discernible in liver than in brain tissue. The liver segment was suspended in a bowl of degassed water with 2.54-cm-wide strips of tape. A rubber acoustic absorber was placed at the bottom of a glass container at a slight angle to the normal incidence plane to avoid standing waves and large reflections. Two thermocouple probes were connected to a dual input datalogger (Omega Engineering, Inc., Stamford, CT, USA), which was subsequently connected to a PC. In order to monitor the temperature rise induced by the FUS transducer, one of the thermocouples (Physitemp Instruments, Inc., Clifton, NJ, USA; type: copper-constantan, needle diameter: 0.33 mm) was placed through the lateral side of the liver, in a plane perpendicular to the FUS transducer beam axis. The temperatures of the container and liver were maintained at a constant temperature of 37
• C by placing the container on a heated surface (Corning, Inc., Acton, MA, USA), while the water temperature was monitored with a second thermocouple (Omega Engineering, Inc., Stamford, CT, USA; type: copper-constantan, needle diameter: 3.18 mm). The water was routinely stirred in order to ensure uniform temperature. The FUS transducer was positioned so that its focus was placed below the surface of the liver segment and at the thermocouple tip by imaging with the diagnostic transducer in a three-dimensional raster scan. The temperature rise was induced by the FUS transducer using the same sonication parameters used in the thermal deposition simulations and in vivo experiments.
Comparison between transcranial simulations and ex vivo skull experiments.
Relative skull attenuation values were obtained by calculating the difference between the pressure amplitude measured after propagation through the skull and the pressure amplitude measured in water only and then dividing the total by the pressure amplitude in water only. The change in FWHM intensity was calculated by calculating the difference between the FWHM intensity through the skull and that through water only and then dividing by the FWHM intensity through water only. The displacement of the focal point was found by subtracting the locations of the peaks of the foci corresponding to the two cases. The attenuation, change in the FWHM intensity and focal point displacement values of the ex vivo skull experiments were obtained by averaging over six values measured in six different skulls.
In vivo ultrasound-induced BBB opening study
In vivo BBB opening experiments were performed and monitored in two steps: (1) targeting and opening of the BBB through the intact skin and skull outside the MRI scanner and (2) monitoring of the BBB opening using slow-contrast diffusion high-resolution MRI (figure 4).
Animal preparation.
A total of nine mice (Harlan, Indianapolis, IN, USA; mass: 25 to 30 g, strain: C57BL/6, sex: male) were used. The mice were anesthetized with a mixture of ketamine (Fort Dodge Animal Health, Fort Dodge, IA, USA; concentration: 75 mg per kg of body mass) and xylazine (Ben Venue Laboratories, Bedford, OH, USA; concentration: 3.75 mg per kg of body mass). Before sonication, the fur on the top of the mouse heads was completely removed using an electric trimmer and a depilatory cream. Between sonication and MRI scanning, the mice were switched to the administration of isoflurane to simplify the long anesthesia procedure necessary for MRI scanning (Moreno et al 2006 . The respiration rate was monitored during all imaging procedures. A mouse was rescanned 28 h after sonication and then prepared for histology (see section 2.3.5). A 28 h delay was chosen to allow for the mouse to recuperate after the initial MRI scan. The other eight mice were euthanized immediately after MRI scanning. All procedures used on the mice were approved by the Columbia University Institutional Animal Care and Use Committee.
Experimental setup.
The same ultrasound system and equipment setup described in the validation of simulation experiments were used for the following in vivo experiments. Each mouse was anesthetized and placed prone on a table with its head stabilized on a paper bedding (figure 2). A degassed water-filled container with the bottom made of thin acoustically and optically transparent Saran Wrap (Saran; SC Johnson, Racine, WI, USA) was placed on top of the mouse head. Ultrasound gel was used to eliminate any air trapped between the water container and the mouse skin in order to eliminate the impedance mismatch. Finally, the FUS transducer was placed in the water container with its beam axis perpendicular to the surface of the skull.
The focus of the transducer was positioned in the mouse brain using a grid positioning method described in a previous study . The beam axis of the transducer was aligned 2 mm away from the sagittal and lambdoid sutures and the focal point was placed 3 mm beneath the top of the left parietal bone of the skull. In this placement, the focus of the FUS beam would overlap with the left hippocampus and the left posterior cerebral artery (PCA) (figures 3(a) and (b)). The right hippocampus was not targeted and was used as the control. Pulsed wave FUS (burst rate: 10 Hz, burst duration: 20 ms, duty cycle: 20%) was applied through the intact skin and skull in a series of 2-4 shots. Each shot consisted of 30 s of sonication. A 30 s interval between each shot allowed the heat to dissipate. The FUS sonication procedure was performed once in each mouse brain.
FUS-induced BBB opening was studied in two different sets of experiments in order to (1) roughly determine the acoustic pressure and microbubble concentration necessary to induce the BBB opening noninvasively and locally on the left hippocampus and (2) analyze the spatio-temporal nature of gadolinium deposition through BBB openings using MRI. In the first set of experiments, a total of four mice were used. Each mouse was injected intravenously (IV) via the tail vein approximately 1 min prior to sonication (figure 4) with a bolus of 50 µl of ultrasound contrast agents (Optison TM ; GE Healthcare, Chalfont St. Giles, UK) constituting of microbubbles (mean diameter: 3.0-4.5 µm, concentration: 5.0-8.0 × 10 8 bubbles per ml). The relatively larger amount of 50 µl than what was used before was administered because tail vein injections were difficult to perform, and it was necessary to ensure that a significant amount of microbubbles entered circulation after injection. Each mouse was then separately sonicated at different acoustic pressure settings of 0.53, 0.67, 0.80 and 1.13 MPa, in a series of four shots of 30 s in duration with 30 s delays between shots. The reported acoustic amplitudes were peak-to-peak pressure values, measured in a degassed water-filled tank and corrected using the skull attenuation values obtained in the ex vivo skull experiments. In the second set of experiments, five mice were separately injected intravenously with a bolus of 25 µl of microbubbles via the tail vein following a cut-down procedure which allowed for high confidence in the amount of Optison TM injected. One mouse was not sonicated and acted as sham while the other mice were sonicated with 0.67 (l = 1) and 0.80 MPa (k = 3).
MRI acquisition.
MR images were obtained with a 9.4 Tesla system (Bruker Medical; Boston, MA, USA). The mice were placed in a plastic tube with a 3.8 cm diameter birdcage coil attached and inserted vertically into the magnet 60-90 min after sonication. Sequential (n = 3-4) T1-weighted spin echo MR images were then obtained (repetition time/echo time (TR/TE): 246.1 ms/10 ms, bandwidth (BW): 50 505.1 Hz, matrix size: 256 × 256, field of view (FOV): 1.92 × 1.92 cm 2 , slice thickness: 0.6 mm, number of excitations (NEX): 5). These images were used to roughly determine whether FUS had caused any tissue damage and to check for any significant field inhomogeneities between the left and right hippocampus. Once the pre-gadolinium scans were completed, 0.5 ml of MRI contrast agent (Omniscan; Amersham Health, AS Oslo, NOR; molecular weight: 573.66), i.e., a molecule that normally does not traverse the BBB (Ford et al 1997) , was administered intraperitoneally (IP) via a catheter to depict the BBB opening . IP injection allowed for the slow uptake of the MRI contrast agent into the bloodstream (Moreno et al 2006 . After injection of the MRI contrast agent, sequential (n = 12-41) T1-weighted images were obtained for 45-180 min. The mouse sonicated at 0.67 MPa in the second set of experiments survived for 28 h post-sonication and the BBB closing was determined by imaging with sequential MRI, injecting a second dosage of gadolinium, and then imaging with sequential MRI again.
MRI analysis.
In both sets of experiments, regions of the MRI were post-processed using four methods to analyze the contrast enhancement. In the first method, the entire image of each MRI image was subtracted by a spatially averaged 11 × 11 pixel region of the right hippocampus that was not sonicated. The left (targeted) and right (control) hippocampi were compared in each mouse and any pixel intensity value above 2.5 standard deviations of the averaged spatial region was determined to be a contrast-enhanced region, indicating a possible BBB opening. Thresholding at 2.5 standard deviations was used because it provided a statistically significant differentiation between unaffected and BBB-opened regions in all mouse experiments. In the second method, the temporal nature of the level of contrast enhancement was quantified in the second set of experiments. A 11 × 11 pixel region of the left and right striatum and a 11 × 11 pixel region of the left and right hippocampi were spatially averaged separately. The normalized increase in signal intensity for each region was measured by subtracting the left region from its equivalent right region and then dividing by the right region for each MRI image. The results from three mice tested were averaged and the standard deviations were recorded. This value was then multiplied by 100%. In this manner, the percentage increase in signal intensity of the left region over the right region was calculated. In the third method, contour maps describing the temporal nature of contrast enhancement were quantified in the second set of experiments. For each mouse, any pixel intensity value above 2.5 standard deviations of the averaged spatial striatum region was determined to be a contrast-enhanced region, indicating a possible BBB opening. This was repeated at various time points and color-coded. Finally, contour maps describing the spatial distribution of contrast enhancement were quantified in the second set of experiments. For each mouse, the regions of contrast enhancement above 2.5, 5.5, 8.5 and 11.5 standard deviations of the averaged spatial striatum regions were determined to be contrast-enhanced regions. Each level was color-coded for more easily distinguishable features. The two contour maps were finally overlaid on top of the corresponding MRI image.
Histology.
After the last MRI sequence was obtained, the mouse sonicated at 0.67 MPa in the second set of experiments was prepared for histology in order to assess the possibility of any macroscopic damage. The mouse was anesthetized with IP-injected ketamine/xylazine and then perfused with saline and 10% neutral buffered formalin. The mouse head was removed and fixed in formalin. The brain was embedded in paraffin, serially sectioned into 6 µm thick horizontal slices and then stained with Haematoxylin and Eosin (H&E).
Results

Simulations and validation experiments
The results of the one-dimensional wave propagation simulation through the skull were compared to a single dimension of the ex vivo skull experimental beam profile results ( figure 5(a) ). The attenuation of the pressure amplitude was 18.6% and 18.1% for the simulation and ex vivo experiments, respectively. The FWHM changes were 0.038 and 0.046 mm in the simulation and ex vivo skull experiment, respectively. There were no significant displacements of the focal point locations for both the simulation and the experiment. The results of heat deposition for both the simulations and the in vitro liver experiments were obtained and compared ( figure 5(b) ). Both simulation and experimental results show that the temperature rise remained under 0.5
• C using the sonication parameters near the threshold to induce the BBB opening (0.67 and 0.80 MPa).
In vivo BBB opening study
Contrast enhancement on the MRI images was used to monitor the opening of the BBB. Diffusion of the MRI contrast agent through BBB-opened regions resulted in an increase in pixel signal intensity on the MRI images. The FUS beam was targeted through the left parietal bone region ( figure 3(a) ) so that the beam overlapped with the left hippocampus ( figure 3(b) ). The orientation of the histology slice in figure 3(b) is similar to that of the MRI slices obtained ( figure 3(c) ). Figure 6 depicts MRI images from the first set of experiments with 50 µl Optison TM intravenously injected. No significant differentiable contrast enhancement ( figure 6(a) ) was observed at the acoustic pressure amplitude of 0.53 MPa. However, contrast enhancement was observed at 0.67 MPa and beyond, and the area of contrast enhancement increased with pressure amplitude (figures 6(b)-(d)). It should be noted that in these sonications, the method used to target the left hippocampus was still being optimized. The accuracy was improved in the second set of experiments. At pressure amplitudes of 0.67 and 0.80 MPa, the area of contrast enhancement decreased when the amount of Optison TM injected was reduced from 50 to 25 µl (figures 6-8). In the second set of experiments, three mice were separately intravenously injected with 25 µl Optison TM and sonicated at 0.0 (sham), 0.67 and 0.80 MPa. The path of gadolinium deposition was tracked over 107, 98 and 180 min, respectively. There was no detectable contrast enhancement in the sham experiment. Figures 7 and 8 show how, after sonication with a pressure amplitude of 0.67 and 0.80 MPa, respectively, the gadolinium first appears in the PCA, or in its immediate vicinity, then slowly permeates throughout the surrounding regions, eventually encompassing the entire left hippocampus. Approximately 28 h after sonication at 0.67 MPa, the mouse was injected with a second equal dose of gadolinium to what was used immediately after sonication, but no contrast enhancement was seen, indicating the BBB closure (figures 8(f)-(i)). The BBB had closed sometime between 4 and 28 h after sonication. The MRI signal intensity was tracked in the striatum and hippocampus regions for over 90 min (figure 9).
Contour maps of the temporal nature and spatial distribution of gadolinium deposition are depicted in figures 10 and 11. Figure 10 depicts the deposition of gadolinium along the vessels and different regions of the brain at different time points. Figure 11 depicts the spatial extent of the deposition of gadolinium. In both figures, there is clearly a non-uniform distribution of gadolinium along the vasculature path. (a) Simulation (solid) and experimental (dotted) lateral beam profile measurements. The units were normalized to the peak intensity at the absence of the skull. The beam was well formed through the mouse skull (red) with 33% attenuation of the acoustic intensity relative to no skull (blue), with a good agreement between simulations and experiments (i.e., the lines overlap). (b) Temperature change in simulations (solid) and in vitro (dotted) experiments at three different pressure amplitudes.
Discussion
Simulations and validation experiments
Previously developed models of transskull wave propagation and thermal deposition in the brain were modified and validated experimentally for use in mice. It has previously been shown that the FUS-induced BBB opening can be applied transcranially in mice (Choi et al skull. Most of the intensity loss, as a result, is due to reflection and refraction phenomena at the skull surface. There was also no significant difference in these properties among different skulls. As a result of these findings, a single-element FUS transducer operating at 1.525 MHz was capable of producing a single, tight focus through the mouse skin and skull and inside the brain while the changes due to aberrations induced by the presence of the skull could be reliably predicted. According to the results of the simulations and ex vivo skull experiments in this study, corrections may be avoided and a well-formed beam may be assumed. This allows for the avoidance of complicated craniotomy procedures and for the reduction of the associated morbidity and mortality rates. Thermal deposition was studied in a theoretical model at the approximate pressure threshold (0.67 MPa) of the BBB opening in vivo. The peak temperature rise at this amplitude in both the simulation and the in vitro liver experiment was below 0.5
• C (figure 5(b)), which is within the allowable temperature levels in diagnostic imaging (Barnett et al 2000) . The simulations accurately predicted the temperature rise induced by the FUS transducer at 0.67 and 0.80 MPa. Deviations between the simulation and experimental data became apparent at 1.10 MPa after the first shot, most likely because heating of the tissue specimen increased the absorption of thermal energy over time. This change in absorption was not factored in our simulations. In addition, the pause between each sonication shot decreased the overall temperature elevation by allowing the heat to dissipate. Acoustic energy at the absence of microbubbles is clearly not enough to trigger a thermally induced physiological effect. However, heat deposition may be enhanced at the cellular or tissue level by microbubbles (Razansky et al 2006) . Since microbubbles were not included in the simulations and in vitro liver experiments, there could still be a significant microbubble-enhanced temperature rise. This will be verified in future experiments. 
In vivo BBB opening study
A molecule that normally does not traverse the BBB was regionally targeted and contained to the entire left hippocampus using a single-element FUS transducer targeted through the intact skin and skull in mice. No craniotomy was required and all experiments were performed completely noninvasively. The BBB opening was determined by contrast enhancement of the MRI signal (Hynynen et al 2001) . T1-weighted MRI was selected because gadolinium increased the T1 signal intensity in the region it permeated (Hynynen et al 2001, Choi et al 2007). In contrast, a previous study showed that gadolinium repressed the T2 signal intensity and thus no new anatomical information could be extracted regarding where the gadolinium was deposited. It should be noted that a contrast-enhanced region within a voxel does not necessarily correspond to a BBB-opened region, since the MRI contrast agent could have diffused throughout the brain's interstitial tissue during the MRI scan time. Nevertheless, the contrast enhancement describes the spatial extent of the molecular delivery and shows that the model drug was delivered to the entire hippocampus (figures 7 and 8). Figures 6-8 show that the area of localization of the contrast enhancement increased with pressure and the amount of microbubbles injected.
Gadolinium was locally deposited in the left hippocampus using pressure amplitudes of 0.67 and 0.80 MPa and 25 µl Optison TM . In these experiments, the spatial behavior of gadolinium diffusion throughout the hippocampi was monitored over an extended period of time by spatially averaging the MRI signal intensity in the hippocampus (figures 7 and 8). It was found that the MRI signal intensity of the left hippocampus increased at a higher rate at 0.80 MPa than at 0.67 MPa, indicating either that the area of the BBB opening was greater or that the effective opening of the BBB was relatively larger at 0.80 MPa. This offers the possibility of controlling the extent of drug delivery by simply adjusting the pressure amplitude applied. However, further study in this area needs to be performed before a concrete conclusion can be drawn.
In addition to tracking the signal intensity level, the path of gadolinium deposition and the shape of contrast enhancement were monitored. Gadolinium began to diffuse at the PCA or within its immediate vicinity and then into the surrounding regions following a non-uniform path (figures 7, 8(a)-(e), 10 and 11). In other words, the shape of contrast enhancement when the FUS beam is targeted over a non-homogeneous vasculature does not correspond to the circular shape of the FUS beam focus (figures 10 and 11). This shape is most apparent in figure 10 at 25 min post-gadolinium injection (blue region). The irregularity of contrast enhancement was also seen in a previous study , using pressure amplitudes greater than 2.0 MPa and a different Optison TM concentration. There is clear indication that the larger vessels or the regions within their immediate vicinity (relative to the pixel size of less than ∼75 µm) are more sensitive to the BBB opening. This is in good agreement with what has been observed microscopically with brain arterioles exhibiting a greater BBB opening than capillaries . The implication of this finding is that the brain region that the FUS beam targets will have a specific drug deposition behavior that is dependent on the vasculature in the target region. In this study, placing the FUS beam over the PCA was advantageous since it allowed for the model drug to be delivered to the entire left hippocampus. So, the question arises: what are the differences in behavior between targeting larger vessels and more homogeneous networks of capillaries? Further analysis of this behavior needs to be studied to compare the effectiveness and safety of the sonication of these different targets.
Figures 8(a)-(d) depict an unexpectedly high contrast enhancement in the right control PCA. This may be because of several reasons including head movement during sonication, simple variability amongst the different mice and the condition of the mouse post-sonication. The same mouse survived, and its BBB was found to close within 28 h after sonication (figures 8(f)-(i)). The same mouse was then sacrificed, and based on high-resolution MRI and preliminary histology, no macroscopic structural damage to the hippocampus was observed (figure 12).
Other than FUS, most of the currently available brain drug delivery methods in the clinic are either noninvasive or localized, but not both simultaneously (Pardridge 2005) . To our knowledge, the only other technique that has the potential to noninvasively and locally open the BBB involves the chemical modification of each drug to allow the molecule to cross the BBB through endogenous transport systems. However, this technique would require special attention and modification of each drug and transport system resulting in significant drug development costs. In contrast, FUS-induced BBB opening has the potential to deliver drugs noninvasively, transiently and locally in the brain for a wide range of drugs. Future studies will be concerned with following the BBB opening behavior over several hours in a single MRI session to determine when and how it closes. In addition, the influence of vessel characteristics will be further studied with a detailed look into the difference in effectiveness and safety of drug delivery in different vascular regions. Finally, methods in combination with the proposed technique will be investigated to noninvasively treat neurodegenerative diseases that affect the hippocampus, such as Alzheimer's disease.
Conclusion
In this paper, the in vivo BBB opening phenomenon and the technical issues associated with opening the BBB in mice were studied with theoretical models as well as ex vivo and in vivo experiments. First, theoretical models of wave propagation and thermal deposition were developed and validated experimentally. It was found that the loss of acoustic energy through the mouse skull was due to reflection and refraction phenomena, not absorption. In addition, in the absence of microbubbles, the acoustic energy used to induce the BBB opening did not generate a temperature rise significant enough to trigger a physiological effect. Secondly, the spatio-temporal nature of gadolinium deposition through ultrasound-induced BBB openings was studied in vivo in mice using high-resolution MRI, which allowed for detailed spatial and temporal analysis of the drug behavior for up to 28 h. Using this technology, it was found that the type of vasculature in the region targeted influences how the drug will be delivered, with the larger vessels or their immediate vicinity being more sensitive to the BBB opening.
